Tobacco smoke, systemic inflammation and the risk of type 2 diabetes.
- 1 March 2006
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 259 (3) , 332
- https://doi.org/10.1111/j.1365-2796.2006.01614.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Elevated Levels of Interleukin-18 Predict the Development of Type 2 DiabetesDiabetes, 2005
- Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle‐aged Finnish men and womenJournal of Internal Medicine, 2005
- Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular diseaseEuropean Heart Journal, 2005
- Inflammatory Markers and Risk of Developing Type 2 Diabetes in WomenDiabetes, 2004
- Low-Grade Systemic Inflammation and the Development of Type 2 DiabetesDiabetes, 2003
- C‐reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular diseaseBritish Journal of Haematology, 2003
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes MellitusJAMA, 2001
- Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1997